13.57
전일 마감가:
$13.45
열려 있는:
$13.5
하루 거래량:
664.20K
Relative Volume:
0.75
시가총액:
$859.78M
수익:
$374.64M
순이익/손실:
$87.19M
주가수익비율:
9.9414
EPS:
1.365
순현금흐름:
$90.65M
1주 성능:
+0.52%
1개월 성능:
-2.37%
6개월 성능:
-5.30%
1년 성능:
+1.57%
Inmode Ltd Stock (INMD) Company Profile
Compare INMD vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
INMD
Inmode Ltd
|
13.57 | 852.18M | 374.64M | 87.19M | 90.65M | 1.365 |
|
ABT
Abbott Laboratories
|
88.67 | 153.59B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
307.94 | 119.69B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
80.38 | 102.97B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
46.76 | 69.72B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.28 | 49.01B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inmode Ltd Stock (INMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-29 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-04-28 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-10-17 | 개시 | BTIG Research | Buy |
| 2024-07-23 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-11-03 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-10-13 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2023-03-29 | 개시 | UBS | Buy |
| 2023-02-17 | 다운그레이드 | Needham | Buy → Hold |
| 2022-12-21 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-05-18 | 개시 | Needham | Buy |
| 2019-09-03 | 개시 | Barclays | Overweight |
| 2019-09-03 | 개시 | Canaccord Genuity | Buy |
| 2019-09-03 | 개시 | Robert W. Baird | Outperform |
| 2019-09-03 | 개시 | UBS | Buy |
모두보기
Inmode Ltd 주식(INMD)의 최신 뉴스
INMD Q1 2026 Earnings: EPS Misses Estimates Despite Slight Stock UptickProfit Recovery Report - newsline.com
INMD Q1 2026 Earnings: EPS Misses Estimates by 17.4%, Stock DeclinesEarnings Miss Streak - newsline.com
InMode Investor Deadline Approaching - TMX Newsfile
InMode Q1 2026 slides: revenue beats amid margin pressure, stock falls - Investing.com
Technical Reactions to INMD Trends in Macro Strategies - Stock Traders Daily
InMode Ltd. (INMD) Presents at Jefferies Global Healthcare Conference 2026Slideshow (NASDAQ:INMD) 2026-06-04 - Seeking Alpha
INMD Stock Chart | INMODE LTD (NASDAQ:INMD) - ChartMill
INMD: Flat revenue outlook, margin pressure, and new products set the stage for future growth - TradingView
InMode Ltd stock (IL0011356806): Nasdaq shares steady as investors look ahead to next earnings updat - AD HOC NEWS
INMD Q1 2026 Earnings: EPS Misses Estimates by 17.44%, Shares Edge LowerPost-Earnings Drift - The Legal Advocate
InMode Q1 2026 earnings preview - MSN
InMode Ltd. poised for growth with new tech, global expansion, and strong financials despite US market challenges - Pluang
InMode: My Pick For A Major Turnaround In 2026 And 2027 (NASDAQ:INMD) - Seeking Alpha
Inmode Ltd (INMD) Reports Solid Numbers in a Soft Market - Insider Monkey
[Form 3] InMode Ltd. Initial Statement of Beneficial Ownership - Stock Titan
InMode (NASDAQ: INMD) CFO lists direct, spousal shares and RSU awards - Stock Titan
15 Best Micro and Small Cap Stocks to Buy According to Jim Simons’ Renaissance Technologies - Insider Monkey
INMD Q1 2026 Earnings: EPS Misses Estimates as Company Faces HeadwindsNet Income Trends - newsline.com
Trading the Move, Not the Narrative: (INMD) Edition - Stock Traders Daily
INMD Q1 2026 Earnings: Earnings Miss as EPS Falls Short of EstimatesFull Year Guidance - newsline.com
Tranche Update on InMode Ltd.'s Equity Buyback Plan announced on March 13, 2026. - marketscreener.com
InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Mos - GuruFocus
INMD Technical Analysis | Trend, Signals & Chart Patterns | INMODE LTD (NASDAQ:INMD) - ChartMill
Should I Buy INMD (InMode Ltd.) | AI Analysis, Technical & News Insights - Kavout
InMode names new board chairman and CFO - Investing.com UK
InMode Ltd. Announces the Appointment of Moshik Itzkovich as Chief Financial Officer, Effective May 20, 2026 - marketscreener.com
InMode Ltd. Announces the Appointment of Shlomo Nass as Chairman of the Board of Directors , Effective May 20, 2026 - marketscreener.com
InMode Names Shlomo Nass Chair; Moshik Itzkovich Appointed as CFO - Moomoo
InMode Names Moshik Itzkovich Chief Financial Officer >INMD - Moomoo
InMode names new board chairman and CFO By Investing.com - Investing.com South Africa
InMode Reshapes Leadership with New Chairman and CFO in May 2026 - TipRanks
InMode appoints Dr. Shlomo Nass as chairman of the board and Moshik Itzkovich as chief financial officer - marketscreener.com
Leadership shakeup at InMode (Nasdaq: INMD) brings new chairman and CFO - Stock Titan
InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer - PR Newswire
InMode Ltd stock (IL0011356806): shares under pressure after Q1 revenue drop and cautious outlook - AD HOC NEWS
InMode Ltd stock (IL0011356806): Q1 results keep US-focused medtech in focus - AD HOC NEWS
InMode Ltd stock (IL0011356806): Recognized among top aesthetic devices leaders - AD HOC NEWS
(INMD) Volatility Zones as Tactical Triggers - Stock Traders Daily
InMode to Present at Upcoming Investor Conferences and Events - GuruFocus
InMode Ltd. to Present at Investor Conferences and Events - geneonline.com
InMode to Present at Upcoming Investor Conferences and Events – Company Announcement - Financial Times
Outgoing InMode CFO to appear at June 3 Jefferies event - Stock Titan
TradingKey - TradingKey
InMode Ltd. (NASDAQ:INMD) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
InMode Is Maintained at Neutral by Baird - Moomoo
CCORF Maintains InMode(INMD.US) With Hold Rating, Maintains Target Price $15 - Moomoo
InMode Ltd. (NASDAQ:INMD) Q1 2026 Earnings Call Transcript - Insider Monkey
InMode (NASDAQ:INMD) Price Target Lowered to $14.00 at Robert W. Baird - MarketBeat
InMode Q1 2026 slides: revenue beats amid margin pressure, stock falls By Investing.com - Investing.com South Africa
InMode Share Fall After Q1 Non-GAAP Earnings Miss Estimates - Moomoo
Needham Maintains InMode(INMD.US) With Hold Rating - Moomoo
Inmode Ltd (INMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):